Hayes, now a part of symplr
  • Payer Solutions
    • Evidence Solutions
    • Services and Technology
  • About Hayes
    • Mission
    • Origins
    • Careers
    • Contact Us
  • Client Login
  • Publications
      • Evidence Analysis


      • Health Technology Assessments


      • Evolving Evidence Review

      • Precision Medicine


      • Clinical Utility Evaluation


      • Molecular Test Assessment


      • Precision Medicine Insights

      • Horizon Scanning


      • Emerging Technology Report

Select Page
  • Payer Solutions
    • Evidence Solutions
    • Services and Technology
  • About Hayes
    • Mission
    • Origins
    • Careers
    • Contact Us
  • Client Login
  • Publications
      • Evidence Analysis


      • Health Technology Assessments


      • Evolving Evidence Review

      • Precision Medicine


      • Clinical Utility Evaluation


      • Molecular Test Assessment


      • Precision Medicine Insights

      • Horizon Scanning


      • Emerging Technology Report

Zolgensma (Onasemnogene Abeparvovec-xioi) for Spinal Muscular Atrophy

by TractManager | Oct 31, 2019 | Emerging Technology Report

Zolgensma (onasemnogene abeparvovec-xioi; formerly AVXS-101) is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric patients < 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor...

Cyanoacrylate Embolization (VenaSeal Closure System) for the Treatment of Varicose Veins

by TractManager | Oct 31, 2019 | Health Technology Assessment

Health Problem: Varicose veins are dilated, thickened, elongated, and twisted blood vessels that may appear thread-like or as grape-like clusters under the skin, most often on the legs. They are manifestations of chronic venous insufficiency, a condition characterized...

Zolgensma (Onasemnogene Abeparvovec-xioi) for Spinal Muscular Atrophy

by TractManager | Oct 31, 2019 | Emerging Technology Report

Zolgensma (onasemnogene abeparvovec-xioi; formerly AVXS-101) is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric patients < 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor...

Proton Beam Therapy for Treatment of Head and Neck Cancer

by TractManager | Oct 30, 2019 | Health Technology Assessment

Health Problem: Head and neck cancer (HNC) accounts for approximately 4% of all cancers in the United States, with an estimated 65,410 new HNC diagnoses during 2019 and an estimated 14,620 deaths from the disease. HNC can have a negative impact on a person’s...

Inebilizumab for Neuromyelitis Optica Spectrum Disorder

by TractManager | Oct 28, 2019 | Emerging Technology Report

Inebilizumab is an investigational anti-CD19 monoclonal antibody. It was developed in response to the unmet treatment needs of patients with neuromyelitis optica spectrum disorder (NMOSD), a rare and debilitating autoimmune demyelinating disease that primary affects...
« Older Entries

Recent Posts

  • Melphalan Hepatic Delivery System (Hepzato Kit) for Liver-Dominant Metastatic Ocular Melanoma
  • Atidarsagene Autotemcel for Metachromatic Leukodystrophy
  • Pulmonary Artery Denervation (PADN) Catheter (Pulnovo Medical) for Pulmonary Arterial Hypertension
  • Therapeutic Intravascular Ultrasound (TIVUS) System (SoniVie) for Pulmonary Hypertension
  • Humacyl Acellular Vessel for Vascular Trauma

Recent Comments

    Archives

    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • September 2014
    • August 2014
    • June 2014
    • May 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • December 2013
    • November 2013
    • October 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • August 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • June 2009
    • May 2009
    • March 2009
    • February 2009
    • November 2008
    • September 2008
    • July 2008
    • May 2008

    Categories

    • Clinical Utility Evaluation
    • Contract Management
    • COVID-Articles
    • COVID-News
    • Emerging Technology Report
    • Evolving Evidence Review
    • Health Technology Assessment
    • Molecular Test Assessment
    • News
    • Precision Medicine Insights
    • Precision Therapy Assessment
    • Publications
    • Strategic Sourcing

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
      • About Hayes
      • Careers

    • Payer Evidence Solutions
    • Services and Technology
    • Publications

    • Contact Us
    • 855-527-9669
    • accountservices@hayesinc.com
    • Follow
    • Follow
    • Follow

    Client Login

    Log In

    Copyright © 2021 Hayes, a symplr company | Privacy Policy

    This site uses cookies. By continuing to use this website, you agree to their use. For details, please review our Privacy Policy